Praxsyn Corp. Bundle
From Pet Flights to Pharmaceuticals: What's the Story of Praxsyn Corp.?
Praxsyn Corporation, a name now synonymous with healthcare solutions, has a surprisingly diverse past. Founded in 2005 in Las Vegas, Nevada, this Praxsyn Corp. SWOT Analysis reveals a company that has undergone a significant transformation. Its journey offers a fascinating look at strategic pivots and the evolution of a business. This brief history explores the key milestones that shaped Praxsyn Corporation into what it is today.
The Praxsyn company's early years, initially focused on pet flight services, stand in stark contrast to its current role as a pharmaceutical company. The shift in March 2014, marked a pivotal moment, redirecting its focus towards the healthcare industry. Understanding Praxsyn Corp.'s history provides crucial context for evaluating its current business overview, market position, and future plans within the dynamic landscape of drug development and healthcare services.
What is the Praxsyn Corp. Founding Story?
The story of Praxsyn Corp. begins with a significant transformation. Initially, the company was established in Illinois on June 5, 2005, under the name American Antiquities, Inc. (AAI). This early phase set the stage for what would become a dynamic journey in the business world.
The company's path took a sharp turn in 2010 when it became Pet Airways, Inc. (PAI) through a reverse acquisition. This shift marked the beginning of its presence on the OTC QB market under the symbol 'PAWS'. PAI offered pet travel services, utilizing a reservation system for its operations.
A pivotal moment arrived on September 26, 2013, when the company announced its strategic shift to the pharmaceutical industry, along with a name change to Praxsyn Corporation and reincorporation in Nevada. This strategic pivot was cemented with the acquisition of Mesa Pharmacy, Inc., completed on March 31, 2014. This move was crucial for Praxsyn's focus on healthcare, specifically in managing workers' compensation accounts receivable. The company was founded by Wiesel Daniel and Alysa Binder in Las Vegas, NV.
Key Milestones
Praxsyn Corp.'s evolution showcases adaptability and strategic foresight.
- June 5, 2005: American Antiquities, Inc. (AAI) is incorporated in Illinois.
- August 2010: AAI undergoes a reverse acquisition and becomes Pet Airways, Inc. (PAI).
- September 26, 2013: Announcement of transition to the pharmaceutical industry and name change to Praxsyn Corporation.
- March 2014: Praxsyn Corporation officially adopts its new name.
- March 31, 2014: Acquisition of Mesa Pharmacy, Inc.
For more information about the company's values, you can read the article about Mission, Vision & Core Values of Praxsyn Corp.
Praxsyn Corp. SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
What Drove the Early Growth of Praxsyn Corp.?
Following its transformation in March 2014, Praxsyn Corp, a pharmaceutical company, shifted its focus to healthcare, supplying medications and services to medical practitioners. This marked the beginning of its early growth and expansion phase, with key acquisitions and strategic initiatives shaping its trajectory. The company's early years were characterized by diversification and a focus on specific market segments.
Acquisitions and Subsidiaries
A significant early move was the acquisition of Mesa Pharmacy, Inc., which became a subsidiary focused on workers' compensation accounts receivable. Praxsyn also established Nevada Health RX, Inc. (NHRX) to market medical supplies through direct sales, and Praxsyn Capital Corporation (PraxCapita) to offer revenue cycle management solutions for healthcare providers. These acquisitions and subsidiaries were crucial for expanding its reach.
Product Portfolio and Market Focus
Praxsyn expanded its offerings to include non-narcotic medications for pain management, erectile dysfunction, and metabolic therapies. These products were primarily provided to patients covered under the California workers' compensation system and preferred provider contracts. The company also engaged in retail pharmacy and medical supplies and equipment through Praxsyn Medical Inc.
Executive and Operational Changes
In 2016, Praxsyn announced executive changes, including the appointment of Daniel Oswald as Chief Financial Officer. The company moved its headquarters from Irvine, California, to Las Vegas, Nevada, in 2017. By December 2018, Maxwell J. Korbin II joined as CFO and Chief Compliance Officer, focusing on restructuring and generating free cash flow.
Financial Performance and Employee Numbers
As of September 2015, Praxsyn Corp had a trailing 12-month revenue of $63.5 million. The company employed approximately 71-75 employees during this period. These figures provide a snapshot of the company's financial performance during its early growth phase.
Praxsyn Corp. PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
What are the key Milestones in Praxsyn Corp. history?
The Praxsyn Corp journey has been marked by significant shifts and developments. From its origins to its current status, the company's history reflects strategic decisions and responses to various challenges within the pharmaceutical sector. The evolution of Praxsyn Corp. highlights its adaptability and efforts to navigate the complexities of the healthcare industry.
| Year | Milestone |
|---|---|
| March 2014 | Transformation from The PAWS Pet Company, Inc. to Praxsyn Corporation, signaling a strategic shift to focus on healthcare. |
| 2014 | Acquisition of Mesa Pharmacy, Inc., which became central to its operations in workers' compensation accounts receivable. |
| March 2020 | Trading in Praxsyn's stock was temporarily suspended by the SEC due to concerns about the accuracy of claims made in press releases. |
| April 2020 | The SEC filed a civil lawsuit against Praxsyn and its CEO, Frank J. Brady, alleging false and misleading statements. |
| July 2023 | Daniel Oswald resigned as CEO and sole board member, followed by Sean Daly's appointment as his replacement. |
Praxsyn Corp's innovations have centered on developing non-narcotic and non-habit-forming medications. These medications are designed for pain management, erectile dysfunction, and metabolic therapies, delivered through various methods.
Focus on Pain Management
The company prioritized the creation of alternative pain relief solutions. These were designed to avoid the addictive properties of traditional opioids.
Erectile Dysfunction Treatments
Praxsyn Corp. expanded its portfolio to include treatments for erectile dysfunction. This aimed to meet the growing demand for such medications.
Metabolic Therapies
The company also invested in the development of metabolic therapies. This reflects a broader approach to healthcare solutions.
Diverse Delivery Methods
Praxsyn Corp. utilized various delivery methods, including transdermal creams and oral capsules. This offered patients different options.
Praxsyn Corp. has faced several challenges, including regulatory compliance issues and legal battles. These issues have significantly impacted the company's operations and financial standing.
Regulatory Compliance
The company has struggled with regulatory compliance, particularly regarding the accuracy of statements made in press releases. This led to investigations and suspensions.
Legal Issues
Praxsyn Corp. faced a civil lawsuit from the SEC, alleging false and misleading statements. This lawsuit further complicated the company's legal standing.
Financial Filings
The company has been working to become current with its financial filings. This has been a key step in restoring investor confidence.
Leadership Transitions
Frequent leadership changes, such as the CEO's resignation in July 2023, have introduced instability. These transitions often require strategic adjustments.
Praxsyn Corp. Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What is the Timeline of Key Events for Praxsyn Corp.?
The Praxsyn Corp, a pharmaceutical company, has navigated a complex path since its inception, marked by strategic shifts and significant events. This brief history of Praxsyn Corp reflects its evolution from its early years to its current status, highlighting key milestones in its journey within the drug development and healthcare sectors.
| Year | Key Event |
|---|---|
| June 5, 2005 | Incorporated in Illinois as American Antiquities, Inc. (AAI). |
| August 13, 2010 | Completed reverse acquisition with Pet Airways, Inc. (PAI), becoming The PAWS Pet Company, Inc. |
| September 26, 2013 | Announced plans to change name to Praxsyn Corporation and reincorporate in Nevada, shifting focus to pharmaceuticals. |
| March 2014 | Name officially changed to Praxsyn Corporation. |
| March 31, 2014 | Acquired Mesa Pharmacy, Inc., solidifying its entry into healthcare. |
| April 15, 2016 | Issued a letter to shareholders from the Chairman and CEO regarding business and operations, highlighting efforts to reduce debt and inefficiencies. |
| 2017 | Moved headquarters from Irvine, California, to Las Vegas, Nevada. |
| September 14, 2018 | Elected new board members: Dr. Sanjeev Kaila, Daniel A. Barretto, and Thomas J. Patire. |
| December 18, 2018 | Maxwell J. Korbin II appointed as CFO and CCO, focusing on financial restructuring. |
| March 25, 2020 | SEC temporarily suspended trading in Praxsyn stock due to questions regarding N95 mask claims. |
| April 28, 2020 | SEC filed civil lawsuit against Praxsyn and its CEO for alleged false statements regarding N95 masks. |
| July 12, 2023 | Daniel Oswald resigned as CEO, and Sean Daly was appointed as the new CEO. |
Current Focus
Praxsyn Corp is currently focused on completing outstanding financial filings to become current. This is a crucial step for the company to regain compliance and transparency.
Future Strategies
The company is exploring financing, business development, and restructuring opportunities. These efforts are aimed at improving its financial performance and efficiency.
Legal and Financial Matters
Praxsyn continues to pursue unclaimed property in the name of Mesa Pharmacy, Inc., held by the State of California. It also awaits updates on Mesa Pharmacy receivables litigation.
Long-Term Goals
The company's long-term vision involves enhancing the financial performance and efficiency of its healthcare assets. This aligns with its commitment to improving patient lives.
Praxsyn Corp. Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What is Competitive Landscape of Praxsyn Corp. Company?
- What is Growth Strategy and Future Prospects of Praxsyn Corp. Company?
- How Does Praxsyn Corp. Company Work?
- What is Sales and Marketing Strategy of Praxsyn Corp. Company?
- What is Brief History of Praxsyn Corp. Company?
- Who Owns Praxsyn Corp. Company?
- What is Customer Demographics and Target Market of Praxsyn Corp. Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.